These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34938173)

  • 41. Abnormal cortical networks in mild cognitive impairment and Alzheimer's disease.
    Yao Z; Zhang Y; Lin L; Zhou Y; Xu C; Jiang T;
    PLoS Comput Biol; 2010 Nov; 6(11):e1001006. PubMed ID: 21124954
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structural and Functional Thalamic Changes in Parkinson's Disease With Mild Cognitive Impairment.
    Li MG; He JF; Liu XY; Wang ZF; Lou X; Ma L
    J Magn Reson Imaging; 2020 Oct; 52(4):1207-1215. PubMed ID: 32557988
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The combination of apolipoprotein E4, age and Alzheimer's Disease Assessment Scale - Cognitive Subscale improves the prediction of amyloid positron emission tomography status in clinically diagnosed mild cognitive impairment.
    Ba M; Ng KP; Gao X; Kong M; Guan L; Yu L;
    Eur J Neurol; 2019 May; 26(5):733-e53. PubMed ID: 30561868
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of Chronic Tinnitus on Metabolic and Structural Changes in Subjects With Mild Cognitive Impairment.
    Lee SY; Kim H; Lee JY; Kim JH; Lee DY; Mook-Jung I; Kim YH; Kim YK
    Front Aging Neurosci; 2020; 12():594282. PubMed ID: 33328974
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Integration and relative value of biomarkers for prediction of MCI to AD progression: spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers.
    Da X; Toledo JB; Zee J; Wolk DA; Xie SX; Ou Y; Shacklett A; Parmpi P; Shaw L; Trojanowski JQ; Davatzikos C;
    Neuroimage Clin; 2014; 4():164-73. PubMed ID: 24371799
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gray matter atrophy associated with mild cognitive impairment in Parkinson's disease.
    Chen FX; Kang DZ; Chen FY; Liu Y; Wu G; Li X; Yu LH; Lin YX; Lin ZY
    Neurosci Lett; 2016 Mar; 617():160-5. PubMed ID: 26742642
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Validation study of the Alzheimer's Disease Assessment Scale-Cognitive Subscale for people with mild cognitive impairment and Alzheimer's disease in Chinese communities.
    Yang H; Cheng Z; Li Z; Jiang Y; Zhao J; Wu Y; Gu S; Xu H
    Int J Geriatr Psychiatry; 2019 Nov; 34(11):1658-1666. PubMed ID: 31347192
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An MRI brain atrophy and lesion index to assess the progression of structural changes in Alzheimer's disease, mild cognitive impairment, and normal aging: a follow-up study.
    Zhang N; Song X; Zhang Y; Chen W; D'Arcy RC; Darvesh S; Fisk JD; Rockwood K;
    J Alzheimers Dis; 2011; 26 Suppl 3():359-67. PubMed ID: 21971475
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patterns of Grey Matter Atrophy at Different Stages of Parkinson's and Alzheimer's Diseases and Relation to Cognition.
    Kunst J; Marecek R; Klobusiakova P; Balazova Z; Anderkova L; Nemcova-Elfmarkova N; Rektorova I
    Brain Topogr; 2019 Jan; 32(1):142-160. PubMed ID: 30206799
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Exploring Structural and Functional Brain Changes in Mild Cognitive Impairment: A Whole Brain ALE Meta-Analysis for Multimodal MRI.
    Gu L; Zhang Z
    ACS Chem Neurosci; 2019 Jun; 10(6):2823-2829. PubMed ID: 30808171
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vivo MRI Structural and PET Metabolic Connectivity Study of Dopamine Pathways in Alzheimer's Disease.
    Iaccarino L; Sala A; Caminiti SP; Presotto L; Perani D;
    J Alzheimers Dis; 2020; 75(3):1003-1016. PubMed ID: 32390614
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Topological Abnormalities of Functional Brain Network in Early-Stage Parkinson's Disease Patients With Mild Cognitive Impairment.
    Chen X; Liu M; Wu Z; Cheng H
    Front Neurosci; 2020; 14():616872. PubMed ID: 33424546
    [TBL] [Abstract][Full Text] [Related]  

  • 53. White matter lesion load is associated with resting state functional MRI activity and amyloid PET but not FDG in mild cognitive impairment and early Alzheimer's disease patients.
    Zhou Y; Yu F; Duong TQ;
    J Magn Reson Imaging; 2015 Jan; 41(1):102-9. PubMed ID: 24382798
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dynamics of brain structure and cognitive function in the Alzheimer's disease neuroimaging initiative.
    Song X; Mitnitski A; Zhang N; Chen W; Rockwood K;
    J Neurol Neurosurg Psychiatry; 2013 Jan; 84(1):71-8. PubMed ID: 23123510
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluating the association between brain atrophy, hypometabolism, and cognitive decline in Alzheimer's disease: a PET/MRI study.
    Chen Y; Wang J; Cui C; Su Y; Jing D; Wu L; Liang P; Liang Z
    Aging (Albany NY); 2021 Feb; 13(5):7228-7246. PubMed ID: 33640881
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alterations of Brain Networks in Alzheimer's Disease and Mild Cognitive Impairment: A Resting State fMRI Study Based on a Population-specific Brain Template.
    Luo Y; Sun T; Ma C; Zhang X; Ji Y; Fu X; Ni H
    Neuroscience; 2021 Jan; 452():192-207. PubMed ID: 33197505
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Connectivity Between Brain Networks Dynamically Reflects Cognitive Status of Parkinson's Disease: A Longitudinal Study.
    Klobušiaková P; Mareček R; Fousek J; Výtvarová E; Rektorová I
    J Alzheimers Dis; 2019; 67(3):971-984. PubMed ID: 30776007
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Indirect relation based individual metabolic network for identification of mild cognitive impairment.
    Li Y; Yao Z; Zhang H; Hu B;
    J Neurosci Methods; 2018 Nov; 309():188-198. PubMed ID: 30194954
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gaussian Graphical Models Reveal Inter-Modal and Inter-Regional Conditional Dependencies of Brain Alterations in Alzheimer's Disease.
    Dyrba M; Mohammadi R; Grothe MJ; Kirste T; Teipel SJ
    Front Aging Neurosci; 2020; 12():99. PubMed ID: 32372944
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Longitudinal progression of cognitive decline correlates with changes in the spatial pattern of brain 18F-FDG PET.
    Shokouhi S; Claassen D; Kang H; Ding Z; Rogers B; Mishra A; Riddle WR;
    J Nucl Med; 2013 Sep; 54(9):1564-9. PubMed ID: 23864720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.